close

Enter

Log in using OpenID

Asia-Pacific Cancer Vaccines Market - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

embed
Asia-Pacific Cancer Vaccines Market By Treatment Type (Prophylactic And Therapeutic), By Cancer Type – (Prostate, Cervical, Colorectal, Throat, And Others), By Vaccine Type – ( Tumour Cell, Dendritic Cell, Genetic And Protein/Peptide Vaccines), By E
Asia-Pacific Cancer Vaccines Market was worth USD 0.63 billion in 2018 and estimated to reach
USD 1.46 billion by the end of 2023 with a growing potential of 18.24 %. A cancer vaccine is a
vaccine that either treats existing cancer or avoids advancement of cancer. Vaccines that treat
existing cancer are known as therapeutic cancer vaccines. A number of the vaccines are
"autologous", being made from tests taken from the patient, and are particular to that patient.
A few analysts guarantee that cancerous cells routinely emerge and are pulverized by the
immune system and that tumors form when the immune system neglects to kill them.
A few sorts of cancer, for example, cervical cancer and some liver cancers, are caused by
infections (oncoviruses). Customary vaccines against those infections, for example, HPV vaccine
and hepatitis B vaccine, prevent those sorts of cancer. Different cancers are to some degree
caused by bacterial infection(e.g. stomach cancer and Helicobacter pylori).
One way to deal with cancer vaccination is to isolate proteins from cancer cells and vaccinate
patients against those proteins as antigens, in the expectation of fortifying the immune system
to slaughter the cancer cells. Research on cancer vaccines is in progress for the treatment of
breast, lung, colon, skin, kidney, prostate and different cancers.
Another approach is to produce an immune reaction in situ in the patient utilizing oncolytic
viruses. This approach was utilized as a part of the medication talimogene laherparepvec, a
variant of herpes simplex infection built to specifically duplicate in tumor tissue and to express
the resistant stimulatory protein GM-CSF. This upgrades the anti-tumor safe reaction to tumor
antigens discharged after viral lysis and gives a patient-specific vaccine.
Get
a
comprehensive
overview
of
the
Asia-Pacific
Cancer
Vaccines
Market:
http://www.marketdataforecast.com/market-reports/asia-pacific-cancer-vaccines-market1422/
Asia-Pacific cancer vaccines market has driving factors like increasing number of people
diagnosed with cancer, people getting aware of vaccines, smoking and excessive intake of
alcohol, strong late-stage pipeline vaccines, vendor’s patient-assistance programs. Stringent
regulations for getting approval, cost of vaccines are a few factors restraining the growth of this
market.
Asia-Pacific Cancer Vaccines Market: Segmentation
By Cancer Type

Prostate

Cervical

Anal

Throat

Other cancers
Request
a
sample
to
stay
up-to-date
on
the
main
trends
affecting
this
market: http://www.marketdataforecast.com/market-reports/asia-pacific-cancer-vaccinesmarket-1422/request-sample
By Vaccine Type

Protein and Peptide based

Tumour cell

Dendritic cell

Genetic vaccines

Other Vaccines
By End Users

Cancer Treatment Centres

Research Institutes
Major players influencing the Asia-Pacific cancer vaccines market are Dendreon,
GlaxoSmithKline and Merck. Companies with their products in pipeline are Aduro Biotech,
Advantagene, Advaxis, Agenus, Altor BioScience, Argos Therapeutics, AVAX Technologies,
Bavarian
Nordic, Biothera, Celldex Therapeutics, CureVac, Galena Biopharma, Genexine,
GlobeImmune, Gradalis, Heat Biologics, Immatics, ImmunoCellular Therapeutics, Inovio
Pharmaceuticals, ISA Pharmaceuticals, Juvaris Biotherapeutics, NewLink Genetics, Northwest
Biotherapeutics, NovaRx,
OncoThyreon, Oncovir, Oxford BioMedica, Prima BioMed, Sotio,
Transgene, Ubivac, Vaccinogen and Vaxon Biotech.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business
intelligence. With rich experience in research across various business domains, they cater to
the needs of both individual and corporate clients. From all-encompassing umbrella markets
to extremely specific niche markets covering all the major regions across the globe as part of
the research scope, their research services offer one of a kind specialities with competitive
pricing options. For more information, kindly visit, www.marketdataforecast.com.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: [email protected]
Author
lokesh.mdf
lokesh.mdf14   documents Email
Document
Category
Uncategorized
Views
1
File Size
210 KB
Tags
vaccines
1/--pages
Report inappropriate content